Szerző: Tait D. Shanafelt, MD¹ Victoria Wang² Neil E. Kay, MD³ Curtis A. Hanson, MD⁴ Susan M. O'Brien, MD⁵ Jacqueline C. Barrientos, MD, MS⁶ Diane F Jelinek, PhD⁷ Esteban Braggio, Ph.D.⁸ Jose F. Leis, MD, PhD⁹ Cong Christine Zhang¹⁰ Steven Coutre, MD¹¹ Paul M. Barr, MD¹² Amanda F Cashen, MD¹³ Anthony R. Mato, MD MSCE¹⁴ Avina Singh, MD¹⁵ Michael P. Mullane, MD¹⁶ Richard F. Little, MD, MPH¹⁷ Harry P. Erba, MD, PhD¹⁸ Richard M. Stone, MD¹⁹ Mark Litzow, MD²⁰ Martin S. Tallman, MD^21
1Stanford University, Stanford, CA
²Harvard, Boston, MA
³Division of Hematology, Mayo Clinic, Rochester, MN
⁴Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
⁵Chao Family Comprehensive Cancer Center, Division of Hematology / Oncology, Department of Medicine, University of California Irvine Health, Orange, CA
⁶Department of Medicine, Zucker School of Medicine at Hofstra/Northwell, Lake Success, NY
⁷College of Medicine, Mayo Clinic, Scottsdale, AZ
⁸Division of Hematology/Oncology, Mayo Clinic, Scottsdale, AZ
⁹Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ
¹⁰Kaiser Permanente, Fresno, CA
¹¹Stanford Univ. School of Med., Stanford, CA
¹²Division of Hematology/Oncology, Wilmot Cancer Institute, University of Rochester, Rochester, NY
¹³Department of Medicine, Washington Univ. School of Med., Saint Louis, MO
¹⁴Center for CLL, Memorial Sloan-Kettering Cancer Center, New York, NY; CLL Program, Leukemia Service, Hematologic Malignancies Division, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁵Minnesota Oncology, Burnsville, MN
¹⁶Aurora Cancer Care-Racine, Racine, WI
¹⁷National Cancer Institute, Washington; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD; National Institutes of Health National Cancer Institute, Bethesda, MD
¹⁸University of Alabama at Birmingham, Birmingham, AL
¹⁹Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
²⁰Division of Hematology, Mayo Clinic, Rochester, MN
²¹Memorial Sloan Kettering Cancer Center, New York, NY